These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 28263318)
1. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Lee JK; Wang J; Sa JK; Ladewig E; Lee HO; Lee IH; Kang HJ; Rosenbloom DS; Camara PG; Liu Z; van Nieuwenhuizen P; Jung SW; Choi SW; Kim J; Chen A; Kim KT; Shin S; Seo YJ; Oh JM; Shin YJ; Park CK; Kong DS; Seol HJ; Blumberg A; Lee JI; Iavarone A; Park WY; Rabadan R; Nam DH Nat Genet; 2017 Apr; 49(4):594-599. PubMed ID: 28263318 [TBL] [Abstract][Full Text] [Related]
2. Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence. Nickel GC; Barnholtz-Sloan J; Gould MP; McMahon S; Cohen A; Adams MD; Guda K; Cohen M; Sloan AE; LaFramboise T PLoS One; 2012; 7(4):e35262. PubMed ID: 22536362 [TBL] [Abstract][Full Text] [Related]
3. Using genomics to guide treatment for glioblastoma. Young JS; Prados MD; Butowski N Pharmacogenomics; 2018 Oct; 19(15):1217-1229. PubMed ID: 30203716 [TBL] [Abstract][Full Text] [Related]
4. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing. Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive genetic alteration profiling in primary and recurrent glioblastoma. Neilsen BK; Sleightholm R; McComb R; Ramkissoon SH; Ross JS; Corona RJ; Miller VA; Cooke M; Aizenberg MR J Neurooncol; 2019 Mar; 142(1):111-118. PubMed ID: 30535594 [TBL] [Abstract][Full Text] [Related]
6. 3D spatial organization and network-guided comparison of mutation profiles in Glioblastoma reveals similarities across patients. Dincer C; Kaya T; Keskin O; Gursoy A; Tuncbag N PLoS Comput Biol; 2019 Sep; 15(9):e1006789. PubMed ID: 31527881 [TBL] [Abstract][Full Text] [Related]
7. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244 [TBL] [Abstract][Full Text] [Related]
9. Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma. Georgescu MM; Olar A Acta Neuropathol Commun; 2020 Feb; 8(1):10. PubMed ID: 32014051 [TBL] [Abstract][Full Text] [Related]
10. Toward precision medicine in glioblastoma: the promise and the challenges. Prados MD; Byron SA; Tran NL; Phillips JJ; Molinaro AM; Ligon KL; Wen PY; Kuhn JG; Mellinghoff IK; de Groot JF; Colman H; Cloughesy TF; Chang SM; Ryken TC; Tembe WD; Kiefer JA; Berens ME; Craig DW; Carpten JD; Trent JM Neuro Oncol; 2015 Aug; 17(8):1051-63. PubMed ID: 25934816 [TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal Evolution of the Primary Glioblastoma Genome. Kim J; Lee IH; Cho HJ; Park CK; Jung YS; Kim Y; Nam SH; Kim BS; Johnson MD; Kong DS; Seol HJ; Lee JI; Joo KM; Yoon Y; Park WY; Lee J; Park PJ; Nam DH Cancer Cell; 2015 Sep; 28(3):318-28. PubMed ID: 26373279 [TBL] [Abstract][Full Text] [Related]
12. Toward Precision Oncology in Glioblastoma with a Personalized Cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing. Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106 [TBL] [Abstract][Full Text] [Related]
13. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma. Mahlokozera T; Vellimana AK; Li T; Mao DD; Zohny ZS; Kim DH; Tran DD; Marcus DS; Fouke SJ; Campian JL; Dunn GP; Miller CA; Kim AH Neuro Oncol; 2018 Mar; 20(4):472-483. PubMed ID: 29244145 [TBL] [Abstract][Full Text] [Related]
14. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model. Daher A; de Groot J Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369 [TBL] [Abstract][Full Text] [Related]
16. Imaging genomics of Glioblastoma: state of the art bridge between genomics and neuroradiology. ElBanan MG; Amer AM; Zinn PO; Colen RR Neuroimaging Clin N Am; 2015 Feb; 25(1):141-53. PubMed ID: 25476518 [TBL] [Abstract][Full Text] [Related]
17. Case of multifocal glioblastoma with four fusion transcripts of Samii A; Sorokin M; Kar S; Makovskaia L; Garazha A; Hartmann C; Moisseev A; Kim E; Giese A; Buzdin A Cold Spring Harb Mol Case Stud; 2021 Aug; 7(4):. PubMed ID: 34341009 [TBL] [Abstract][Full Text] [Related]
18. Recognizing and correcting failures in glioblastoma treatment. Shah AH; Graham R; Bregy A; Thambuswamy M; Komotar RJ Cancer Invest; 2014 Jul; 32(6):299-302. PubMed ID: 24766304 [TBL] [Abstract][Full Text] [Related]
19. GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis. Yang Y; Sui Y; Xie B; Qu H; Fang X Genomics Proteomics Bioinformatics; 2019 Aug; 17(4):465-471. PubMed ID: 31811943 [TBL] [Abstract][Full Text] [Related]
20. Genomic characterization of recurrent high-grade astroblastoma. Bale TA; Abedalthagafi M; Bi WL; Kang YJ; Merrill P; Dunn IF; Dubuc A; Charbonneau SK; Brown L; Ligon AH; Ramkissoon SH; Ligon KL Cancer Genet; 2016; 209(7-8):321-30. PubMed ID: 27425854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]